Which Diets Help the Hearts of Folks With Type 1 Diabetes?
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
TUESDAY, July 2, 2024 -- Two well-known healthy diets can lower heart disease risk in people with type 1 diabetes, a new study says.
People who ate similarly to the Mediterranean diet or the DASH diet had lower levels of blood markers that are used in clinical settings to assess heart health risk, researchers reported Sunday at a meeting of the American Society for Nutrition in Chicago.
“Both DASH and Mediterranean diets revealed protective associations, which means these dietary patterns can make a difference when consumed regularly,” researcher Arpita Basu, an associate professor of kinesiology and nutrition sciences at the University of Nevada at Las Vegas, said in a news release.
The new study builds on earlier work in which researchers tied the DASH and Mediterranean diets to lesser fat accumulation around the heart and less hardening of the arteries.
For this study, 1,255 adults were tracked for six years, 563 of whom had type 1 diabetes.
Researchers assessed their diet using questionnaires to see who was eating in ways similar to the Mediterranean or DASH diets.
They found that adults with type 1 diabetes tend to consume high-fat diets, because their condition requires them to cut carbs. They tend to substitute in animal protein, which can be high in saturated fat and cholesterol.
“There is an urgent need to address dietary quality in adults with type 1 diabetes,” Basu said. “In a clinical setting, assessing dietary intakes using the DASH and Mediterranean dietary checklists could be an effective way to identify gaps and improve intakes.”
She added that "specific foods that are part of these dietary patterns, such as olives and nuts in the Mediterranean diet, could be added to the diet even if the entire diet cannot be altered.”
Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-02 23:15
Read more
- Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
- Psychologists' Group Issues First Guidance to Parents on Teen Online Video Use
- Bystanders More Readily Perform CPR If 911 Operator Instructs
- New Alzheimer's prevention trial receives $74.5 million NIH grant
- Syndax Announces Positive Pivotal Topline Results from Relapsed or Refractory mNPM1 AML Cohort in AUGMENT-101 Trial of Revumenib
- Chronic Joint Pain Plus Depression Can Take Toll on the Brain
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions